Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous HNSCC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck
Clin. Cancer Res 2021 Jun 29;[EPub Ahead of Print], R Ferrarotto, M Amit, P Nagarajan, ML Rubin, Y Yuan, D Bell, AK El-Naggar, JM Johnson, WH Morrison, DI Rosenthal, BS Glisson, FM Johnson, C Lu, FE Mott, B Esmaeli, EM Diaz, PW Gidley, RP Goepfert, CM Lewis, RS Weber, JA Wargo, S Basu, F Duan, SS Yadav, P Sharma, JP Allison, JN Myers, ND GrossFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.